GRIFOLS | GRF - Sales Revenues



GRIFOLS reported EUR1.89B in Sales Revenues for its fiscal quarter ending in June of 2025.


Sales Change Date
Alcon AG USD 2.58B 130M Jun/2025
Almirall EUR 275M 9.6M Jun/2025
Amadeus IT EUR 1.63B 2.2M Jun/2025
Amarin USD 72.74M 30.72M Jun/2025
argenx SE USD 842.5M 132.26M Jun/2025
AstraZeneca USD 14.46B 867M Jun/2025
Bayer EUR 10.74B 3B Jun/2025
Cie Automotive EUR 987M 13M Jun/2025
Demant DKK 5.63B 10M Jun/2025
Ence Energia y Celulosa EUR 192.3M 15.8M Jun/2025
Essilor EUR 14.02B 7.17B Jun/2025
Ferrovial EUR 2.41B 350M Jun/2025
Fresenius EUR 5.58B 70M Jun/2025
Fresenius Medical Care EUR 4.79B 90M Jun/2025
Galapagos EUR 70.17M 4.81M Jun/2025
Genmab DKK 5.86B 580M Jun/2025
GlaxoSmithKline GBP 7.99B 470M Jun/2025
GRIFOLS EUR 1.89B 100M Jun/2025
Hikma Pharmaceutical USD 1.59B 18M Dec/2024
Inditex EUR 8.27B 2.94B Apr/2025
Merck EUR 4.43B 850M Jun/2025
Novartis USD 14.05B 821M Jun/2025
Philips EUR 4.34B 241M Jun/2025
Roche Holding CHF 31.64B 883M Dec/2024
Sanofi EUR 9.99B 90M Jun/2025
Smith & Nephew USD 1.55B 140M Jun/2025
UCB EUR 3.49B 129M Jun/2025
Viscofan EUR 312M 4.73M Jun/2025